Fri.Jul 22, 2022

article thumbnail

European regulator recommends Bavarian Nordic's vaccine for monkeypox

Bio Pharma Dive

The positive decision comes as governments aim to expand supply and quicken distribution of the vaccine to combat a widening global outbreak. Separately, the EMA backed approvals of 11 other medicines.

article thumbnail

ASRS conference reveals hopeful outcomes for gene therapy RGX-314 in retinal diseases

Pharmaceutical Technology

Pipeline therapies within the diabetic macular oedema (DME) space have recently gathered interest following the American Society of Retina Specialists (ASRS) Annual Meeting, which took place on 13–16 July. The spotlight was placed on many up-and-coming pharmacotherapies for retinal diseases, one of which was AbbVie’s/Regenxbio’s gene therapy RGX-314.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vertex to move non-opioid painkiller into late-stage tests after FDA agreement

Bio Pharma Dive

Trial results released earlier this year showed potential for the drug, which has become one of Vertex’s top pipeline prospects.

Trials 353
article thumbnail

EC approves amendment of Valneva’s Covid-19 vaccines purchase deal

Pharmaceutical Technology

The European Commission (EC) has approved an advance purchase agreement (APA) amendment for Valneva’s inactivated whole-virus Covid-19 vaccine, VLA2001. The latest move follows remediation discussions based on the notice sent to the company regarding the termination of the initial APA for purchasing vaccine doses this year and the optional doses for next year.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Astellas to bring research units under one roof in new West Coast center

Bio Pharma Dive

The pharma company plans to spend $70 million on the South San Francisco facility, which will house West Coast employees of Astellas Gene Therapies.

article thumbnail

ARS Pharmaceuticals to merge with Silverback Therapeutics

Pharmaceutical Technology

ARS Pharmaceuticals has signed a definitive agreement to merge with Silverback Therapeutics in an all-stock transaction. The combined company will operate under the name ARS Pharmaceuticals and be headquartered in San Diego, California, US, after the completion of the transaction. It will focus on the potential regulatory clearance and commercialisation of ARS’ investigational epinephrine nasal spray, neffy.

More Trending

article thumbnail

Top tweets: Covid-19 headed towards seasonality – and more

Pharmaceutical Technology

Pharmaceutical Technology lists five of the top tweets on infectious diseases in Q2 2022 based on data from GlobalData’s Pharmaceuticals Influencer Platform. The top tweets are based on total engagements (likes and retweets) received on tweets from more than 188 infectious diseases experts tracked by GlobalData’s Pharmaceuticals Influencer platform during the second quarter (Q2) of 2022.

article thumbnail

As new variant spreads, a crucial drug to protect the most vulnerable goes vastly underused

STAT News

Jennifer Padgett has spent 2 1/2 years terrified for her immunocompromised daughter, Hannah. Hannah catches pneumonia like mosquito bites; what could Covid wreak? Their whole family locked down in the early days, rushed to get vaccines when they became available and kept masking and avoiding indoor dining in their small southern town even after the Centers for Disease Control and Prevention loosened restrictions.

Doctors 145
article thumbnail

The first U.S. polio case was discovered in nearly a decade. Should you worry?

NPR Health - Shots

The CDC confirmed that a patient in New York has contracted polio, the first U.S. case since 2013. But most people shouldn't be concerned about contracting the virus because of high vaccination rates.

article thumbnail

Grand Rounds July 15, 2022: Overview of Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Public-Private Partnership and Lessons Learned (Stacey J. Adam, PhD)

Rethinking Clinical Trials

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speaker. Stacey J. Adam, PhD. Associate Vice President, Research Partnerships. Foundation for the NIH. Slides. Keywords. ACTIV, COVID-19, FNIH. Key Points. The normal timeline for public-private partnerships is around 9 months of planning. ACTIV was stood up in about a month, launching on April 17, 2020, to develop a coordinated research response to speed COVID-19 treatment and vaccine options.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Drugmakers are slow to prove medicines that got a fast track to market really work

NPR Health - Shots

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Medicine 128
article thumbnail

Opinion: New price transparency regulations for hospitals, insurers empower patients

STAT News

Many Americans are accustomed to shopping around for the best deal. We can access reams of information that help us make smarter decisions — except when it comes to health care services. For too long, we have been left in the dark when it comes to the cost of medical treatments and procedures. Without a true health care marketplace based on price transparency, Americans will continue to make uninformed decisions that result in spiraling costs for everyone.

article thumbnail

How people, pets and infrastructure can respond to extreme heat

NPR Health - Shots

Climate change is making heat waves more frequent and intense. With much of the U.S. facing a weekend of extreme temperatures, here are some tips for protecting yourself and your loved ones.

115
115
article thumbnail

STAT+: Amazon has big ambitions in primary care. One Medical is just the latest piece of its plan

STAT News

When it comes to primary care, One Medical is hardly Amazon’s first rodeo.  By the time the tech giant made the bombshell announcement that it was buying One Medical on Thursday, it had already aggressively scaled what began as a modest primary care pilot for its Seattle-area employees. Amazon has enlisted two different primary care companies — Care Medical and Crossover Health — to help it expand its services to all 50 states.

111
111
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Biden's symptoms improved despite elevated temperature Thursday night, his doctor says

NPR Health - Shots

President Biden had a slightly elevated temperature last night but his physician says that "his symptoms have improved" as he receives treatment after testing positive for COVID-19 on Thursday.

Doctors 110
article thumbnail

Pfizer, Flynn fined £70m in resurrected epilepsy drug pricing probe

pharmaphorum

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. The CMA delivered a preliminary judgment in the case last year which concluded that Pfizer and Flynn abused a dominant position in phenytoin sodium capsules, causing NHS spending on the drug to balloon from around £2 million a year in 2012 to £50 million the following year.

Drugs 110
article thumbnail

NICE recommends Rhythm’s Imcivree to help treat obesity and control hunger

Pharma Times

The treatment has been developed for people aged six years and over will be available for use across the NHS

article thumbnail

Amazon ratchets up its health ambitions, buying US primary care group

pharmaphorum

Amazon has accelerated its expansion into the healthcare sector with an all-cash deal to acquire One Medical, a US group that provides virtual and in-person primary care services using a subscription fee model. Amazon is buying One Medical for $18 per share, valuing the company at around $3.9 billion and making it one of the online retail giant’s largest-ever acquisitions – and by far its biggest within the health category.

Pharmacy 104
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Acne bacteria, study suggests, thrive when skin oil turns infection-fighting cells into accomplices 

STAT News

Cutibacterium acnes, a crunchy Cheeto-shaped bug that lives on human skin, loves the oily pocket around hair follicles. No face is quite as greasy as that of adolescents, flooded with hormones that grow hair, deepen voices, and ramp up production of sebum, a secretion that makes the skin a moist and protective barrier.  Too little sebum means dry, flaky skin, like patches of eczema.

article thumbnail

Staying Ahead of the Game in Web3: Our Latest Hackathon Win!  

Intouch Solutions

What does a EVERSANA INTOUCH Web3 hackathon win mean for the future of healthcare? It’s a grand question… but let’s explain and see if you agree with us that it’s a very big deal indeed. The Hedera22 global hackathon, which hosted over 2500 participants across 95 different countries, is sponsored by Hedera Hashgraph, one of the leading platforms in the evolving Web3 distributed ledger landscape.

article thumbnail

Opinion: There’s no ‘Moonshot’ or ‘Warp Speed’ for rare diseases. There should be

STAT News

The term “rare disease” is both an apt descriptor and a misnomer. Individually, each rare disease affects a relatively small number of people. But taken together, more than 30 million Americans , and 400 million people worldwide , are affected by one of the 10,000-plus rare diseases — 95% of which have no approved treatment. More than half of those with rare diseases are children, one-third of whom won’t live to celebrate their fifth birthdays.

article thumbnail

Melanoma clinical trials: A Q&A with the Melanoma Research Alliance

Antidote

Skin cancer is more common than any other type of cancer, and melanoma causes a large majority of skin cancer-related deaths. While awareness surrounding melanoma and the importance of sun protection has risen in recent years, CDC research shows that melanoma rates have still doubled over the last three decades.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

STAT+: Pharmalittle: Congress may miss deadline to pass FDA user-fee bill; ViiV is urged to lower price for its HIV prevention drug

STAT News

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still getting sorted out, but we hope to catch up on our reading and hang with our oh-so-busy short person. And what about you? Normally, we would suggest you enjoy the great outdoors, but given the heat, we hesitate to do so, unless you have a Jetsons-like portable air conditioner you can strap on your back.

article thumbnail

Abortion providers see greater interest in sterilization procedures

NPR Health - Shots

In the wake of the Supreme Court overturning Roe v. Wade , clinics report a surge in demand for sterilization procedures.

110
110
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT News

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right.  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

article thumbnail

The new European Unitary Patent system – What you need to know

pharmaphorum

The proposed European unitary patent and unified patent court represents one of the largest changes to the European patent system in a generation. It will usher in a new European patent right (the unitary patent) which will have unitary effect across participating member states. A new court system (the unified patent court or UPC) will also be established to handle litigation not only of the new unitary patents, but also of European patents under the current system that are validated nationally

Drugs 89
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Vicebio targets development of novel vaccines

Pharma Times

Molecular clamp technology is a protein tag that stabilises a wide range of complex viral proteins

article thumbnail

What women truckers can tell us about living and working alone

NPR Health - Shots

American long-haul truckers share wisdom from the road on living where you work (Image credit: Meg Vogel for NPR)

105
105
article thumbnail

Scientists expand entomological research using genome editing

Scienmag

Genome sequencing, where scientists use laboratory methods to determine a specific organism’s genetic makeup, is becoming a common practice in insect research. A greater understanding of insect biology helps scientists better manage insects, both those that are beneficial to the ecosystem and those that damage the food supply and threaten human health by carrying diseases. […].

Genome 82
article thumbnail

The New Hub Features Improving Patient Assistance

Drug Channels

Today’s guest post comes from Ian Ocilka, Senior VP of Client Solutions at ConnectiveRx. Ian shares an overview of The Evolving Role of Hubs and Patient Services , his recent presentation at Informa Connect's Hub and Specialty Model East conference in June. Click here to watch Ian’s full presentation. Read on for Ian’s insights. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drugs 78
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.